| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |